Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

The effect of radiologic imaging studies on the risk of secondary malignancy development in patients with Hodgkin lymphoma.

Beyan C, Kaptan K, Ifran A, Ocal R, Ulutin C, Oztürk B.

Clin Lymphoma Myeloma. 2007 Jul;7(7):467-9.

PMID:
17875235
2.

Low-dose radiation and secondary malignancy: is there a causal relationship?

Lin C, Loberiza FR Jr.

Clin Lymphoma Myeloma. 2007 Jul;7(7):450. No abstract available.

PMID:
17875233
3.

Estimated radiation exposure and cancer risk from CT and PET/CT scans in patients with lymphoma.

Guttikonda R, Herts BR, Dong F, Baker ME, Fenner KB, Pohlman B.

Eur J Radiol. 2014 Jun;83(6):1011-5. doi: 10.1016/j.ejrad.2014.02.015. Epub 2014 Feb 24.

PMID:
24656401
4.

Role of computed tomography on large B-cell non-Hodgkin's lymphoma follow-up and the risk of radiation-induced neoplasm: A retrospective cohort study.

Graña L, Calzado A, Hernández P, Rodríguez R.

Eur J Radiol. 2016 Mar;85(3):673-9. doi: 10.1016/j.ejrad.2015.12.033. Epub 2016 Jan 7.

PMID:
26860683
5.

Ionizing radiation exposure as a result of diagnostic imaging in patients with lymphoma.

Crowley MP, O'Neill SB, Kevane B, O'Neill DC, Eustace JA, Cahill MR, Bird B, Maher MM, O'Regan K, O'Shea D.

Clin Transl Oncol. 2016 May;18(5):533-6. doi: 10.1007/s12094-015-1394-8. Epub 2015 Aug 26.

PMID:
26307754
6.

Ionizing radiation in patients with Crohn´s disease. Estimation and associated factors.

Ciáurriz-Munuce A, Fraile-González M, León-Brito H, Vicuña-Arregui M, Miquélez S, Uriz-Otano J, Jiménez-López C.

Rev Esp Enferm Dig. 2012 Sep;104(9):452-7.

7.
8.

Current imaging follow-up of non-Hodgkin lymphoma exposes patients to significant radiation but does not detect asymptomatic relapses.

Riva E, Oliver C, Pérez Mdel C, Telis O, Díaz L, Mikhael JR.

Leuk Lymphoma. 2016;57(6):1363-6. doi: 10.3109/10428194.2015.1094694. Epub 2015 Oct 15.

PMID:
26374395
9.

Radiation exposure in the acute and short-term management of urolithiasis at 2 academic centers.

Ferrandino MN, Bagrodia A, Pierre SA, Scales CD Jr, Rampersaud E, Pearle MS, Preminger GM.

J Urol. 2009 Feb;181(2):668-72; discussion 673. doi: 10.1016/j.juro.2008.10.012. Epub 2008 Dec 18.

PMID:
19100573
10.

Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study.

Sacchi S, Marcheselli L, Bari A, Marcheselli R, Pozzi S, Luminari S, Lombardo M, Buda G, Lazzaro A, Gobbi PG, Stelitano C, Morabito F, Quarta G, Brugiatelli M.

Haematologica. 2008 Mar;93(3):398-404. doi: 10.3324/haematol.12120. Epub 2008 Feb 11.

11.

Bladder and kidney cancer following cyclophosphamide therapy for non-Hodgkin's lymphoma.

Travis LB, Curtis RE, Glimelius B, Holowaty EJ, Van Leeuwen FE, Lynch CF, Hagenbeek A, Stovall M, Banks PM, Adami J, et al.

J Natl Cancer Inst. 1995 Apr 5;87(7):524-30.

PMID:
7707439
12.

[Positron-emission tomography with fluorine-18-deoxyglucose in the staging and control of patients with lymphoma. Comparison with clinico-radiologic assessment].

Mainolfi C, Maurea S, Varrella P, Alaia C, Imparato C, Alfano B, Abate G, Bazzicalupo L.

Radiol Med. 1998 Jan-Feb;95(1-2):98-104. Italian.

PMID:
9636735
13.

Total estimated effective doses from radiologic imaging modalities of children with cancer: a single center experience.

Özyörük D, Emir S, Demir HA, Kabaçam GB, Tunç B.

World J Pediatr. 2017 Jun;13(3):242-247. doi: 10.1007/s12519-016-0049-3. Epub 2016 Nov 23.

PMID:
27878779
14.

Thyroid neoplasms after therapeutic radiation for malignancies during childhood or adolescence.

Acharya S, Sarafoglou K, LaQuaglia M, Lindsley S, Gerald W, Wollner N, Tan C, Sklar C.

Cancer. 2003 May 15;97(10):2397-403.

15.

Radiation doses originating from diagnostic procedures during the treatment and follow-up of children and adolescents with malignant lymphoma.

Pierobon J, Webber CE, Nayiager T, Barr RD, Moran GR, Gulenchyn KY.

J Radiol Prot. 2011 Mar;31(1):83-93. doi: 10.1088/0952-4746/31/1/005. Epub 2011 Feb 23.

PMID:
21346283
16.

Frequency of surveillance computed tomography in non-Hodgkin lymphoma and the risk of secondary primary malignancies: A nationwide population-based study.

Chien SH, Liu CJ, Hu YW, Hong YC, Teng CJ, Yeh CM, Chiou TJ, Gau JP, Tzeng CH.

Int J Cancer. 2015 Aug 1;137(3):658-65. doi: 10.1002/ijc.29433. Epub 2015 Jan 29.

17.

Non-Hodgkin lymphoma and Hodgkin disease: coregistered FDG PET and CT at staging and restaging--do we need contrast-enhanced CT?

Schaefer NG, Hany TF, Taverna C, Seifert B, Stumpe KD, von Schulthess GK, Goerres GW.

Radiology. 2004 Sep;232(3):823-9. Epub 2004 Jul 23.

PMID:
15273335
18.

Cancer in the offspring of radiation workers: a record linkage study.

Draper GJ, Little MP, Sorahan T, Kinlen LJ, Bunch KJ, Conquest AJ, Kendall GM, Kneale GW, Lancashire RJ, Muirhead CR, O'Connor CM, Vincent TJ.

BMJ. 1997 Nov 8;315(7117):1181-8.

19.

Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors.

Ng AK, Bernardo MV, Weller E, Backstrand K, Silver B, Marcus KC, Tarbell NJ, Stevenson MA, Friedberg JW, Mauch PM.

Blood. 2002 Sep 15;100(6):1989-96.

20.

Pediatric Burkitt's lymphoma and diffuse B-cell lymphoma: are surveillance scans required?

Eissa HM, Allen CE, Kamdar K, Simko S, Goradia P, Dreyer Z, Steuber P, McClain KL, Guillerman RP, Bollard CM.

Pediatr Hematol Oncol. 2014 Apr;31(3):253-7. doi: 10.3109/08880018.2013.834400. Epub 2013 Oct 2.

Supplemental Content

Support Center